Faecal pyruvate kinase isoenzyme type M2 for colorectal cancer screening: A meta-analysis

doi:10.3748/wjg.v18.i30.4004

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 30

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9722)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-8) series.

Item

Count

PDF

730

HTML

8661

Figures (1-3)

170

Tables (1-8)

161

Sum=9722

Aug 14, 2012 (publication date) through Apr 19, 2024

Times Cited of This Article

Times Cited (40)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Aug 14, 2012; 18(30): 4004-4011
Published online Aug 14, 2012. doi: 10.3748/wjg.v18.i30.4004

Full Size Figure Download Figure

Figure 2 Distribution of faecal pyruvate kinase isoenzyme type M2 concentrations in a screening collective of 2787 participants aged from 45 to 65 years[52]. n: Number of test negative; N: Total number of subjects; M2-PK: Pyruvate kinase isoenzyme type M2.

Citation: Tonus C, Sellinger M, Koss K, Neupert G. Faecal pyruvate kinase isoenzyme type M2 for colorectal cancer screening: A meta-analysis. World J Gastroenterol 2012; 18(30): 4004-4011
URL: https://www.wjgnet.com/1007-9327/full/v18/i30/4004.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i30.4004